Cargando…
Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines
Some of the central challenges for developing effective vaccines against HIV and hepatitis C virus (HCV) are similar. Both infections are caused by small, highly mutable, rapidly replicating RNA viruses with the ability to establish long-term chronic pathogenic infection in human hosts. HIV has caus...
Autores principales: | John, Mina, Gaudieri, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195390/ https://www.ncbi.nlm.nih.gov/pubmed/25352836 http://dx.doi.org/10.3389/fmicb.2014.00514 |
Ejemplares similares
-
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design
por: von Delft, Annette, et al.
Publicado: (2016) -
Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection
por: Moise, Leonard, et al.
Publicado: (2014) -
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014) -
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014) -
Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity
por: Pfafferott, Katja, et al.
Publicado: (2011)